GENEVA—The World Health Organization has given the go-ahead for emergency use of Moderna’s COVID-19 vaccine. The mRNA vaccine from the U.S. manufacturer joins vaccines from AstraZeneca, Pfizer-BioNTech, and Johnson & Johnson in receiving the WHO’s emergency use listing. Similar approvals for China’s Sinopharm and Sinovac vaccines are expected in the coming days and weeks, WHO has said. The greenlight for Moderna’s vaccine, announced late Friday, took many months because of delays WHO faced in getting data from the manufacturer. Many countries without their own advanced medical regulatory and assessment offices rely on the WHO listing to decide whether to use vaccines. U.N. children’s agency UNICEF also uses the listing to deploy vaccines in an emergency like the pandemic. The announcement isn’t likely to have an immediate impact on supplies of Moderna’s vaccine for the developing world. The company struck supply agreements with many rich countries, which have already received millions …
-
Recent Posts
-
Archives
- May 2025
- April 2025
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- September 2013
- July 2013
- March 2013
- January 2013
- December 2012
- November 2012
- December 1
-
Meta